Clinical Trial: Efficacy and Safety Study of HRO350 in Patients with Mild-to-moderate Psoriasis (the 'HeROPA' Study).
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Psoriasis
Study Type: INTERVENTIONAL
Official Title: A Phase 2B, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-finding, Efficacy and Safety Study of HRO350 in Patients with Mild-to-moderate Psoriasis (the 'HeROPA' Study).
Brief Summary:
HRO350 contains an oil-based extract from herring roe (Clupea harengus) in soft capsules and contains phospholipids (complex lipids) which are naturally rich in marine polyunsaturated fatty acids.All the lipids in HRO350 are natural components of the human diet.It is not fully known how HRO350 exerts its effects, however there are indications that it might have a modulatory effect on the inflammatory processes involved in causing psoriasis.The study is a randomised, double-blind, placebo controlled, dose finding,…
Read more